(Press-News.org) A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The multi-site trial is spearheaded by the U.S. Army Medical Materiel Development Activity (USAMMDA), part of the U.S. Army Medical Research and Development Command, and supported by a project team that includes representatives from the U.S. Air Force, Army, Navy, and Special Operations Command.
Military veterans are more likely to have PTSD than civilians, according to statistics from the U.S. Department of Veterans Affairs, and service members who deployed to a war zone are more likely to have PTSD than those who did not deploy. Overall, about six percent of the U.S. population will have PTSD at some point in their lives.
People with PTSD have difficulty recovering after experiencing or witnessing a traumatic event. The condition may last months or years, with triggers that can bring back memories of the event, accompanied by intense emotional and physical reactions. Symptoms may include nightmares, avoidance of certain situations, heightened stress reactions, anxiety, and depression, according to the National Institute of Mental Health.
Current treatment for PTSD includes several types of trauma-focused psychotherapy as well as medications to manage symptoms. However, previous research has shown that patients with a military history respond poorly to current drug treatments and psychotherapy compared to non-veteran patients.
Since 1987, over 130 PTSD pharmacotherapeutic trials have been conducted, but only two drugs (paroxetine and sertraline) are approved by the Food and Drug Administration (FDA) specifically to treat the condition. Although other drugs can be prescribed “off-label,” meaning they are FDA-approved for other medical conditions, there is scant data to guide such use in the military population, according to Kimberly del Carmen, Ph.D., a health science product manager at USAMMDA.
“PTSD is heterogenous in nature, meaning that no single biological cause is common to all individuals with PTSD,” said del Carmen. “For that reason, we don’t think there will be one ‘magic pill’ that will work for everyone, so we’re employing an innovative testing strategy called an Adaptive Platform Trial.”
This clinical trial platform design allows for an efficient use of resources with an accelerated schedule in which multiple drugs are simultaneously and sequentially tested. As the trial progresses, drugs that fail will be replaced with new candidates, and those that are successful will “graduate” to the next stage of development.
In addition to evaluating numerous potential PTSD treatments, the trial also will examine several biological indicators to determine whether people with PTSD have some shared characteristics, such as specific biological markers, that can provide insight into designing potential treatments or matching treatments to individuals.
According to del Carmen, three drug candidates that are FDA-approved for conditions other than PTSD were chosen for the first round of testing. Frequent interim analyses of the data will be conducted, and successful testing results will trigger the first of a series of clinical practice guideline decision points, including recommendations for the off-label use of these drugs.
Drugs tested in the future are likely to be novel drugs, since the goal of this effort is to obtain FDA approval of one or more therapeutics for the treatment of PTSD, del Carmen said.
The trial will include 15-20 clinical sites within the United States and is planned to include up to 600 subjects during the testing of the first three drugs over approximately three years.
About USAMMDA
The U.S. Army Medical Materiel Development Activity, part of the U.S. Army Medical Research and Development Command, develops, delivers, and fields critical drugs, vaccines, biologics, devices, and medical support equipment to protect and preserve the lives of Warfighters across the globe. USAMMDA project managers guide the development of medical products for the U.S. Army Medical Department, other U.S. Services, the Joint Staff, the Defense Health Agency, and the U.S. Special Forces community. The process takes promising technology from DoD, industry, and academia to U.S. Forces, from the testing required for U.S. Food and Drug Administration approval or licensing to fielding and sustainment of the finished product.
END
Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel
2023-10-26
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Scientists call for a major investigation into Congo Basin
2023-10-26
Leading researchers have launched a major scientific initiative to investigate - and help protect - the fragile Congo Basin Forest region in central Africa, one of the world’s most important but little understood ecosystems.
They say the Congo Basin Science Initiative will transform the understanding of the Congo Basin, an area of 240 million hectares of contiguous tropical forests that absorb a vast quantity of carbon, which helps to moderate the impact of global climate ...
Politecnico di Milano and Università di Milano-Bicocca awarded an ERC Synergy Grant on next-generation numerical methods for sustainability challenges
2023-10-26
Developing new-generation numerical methods for the technological challenges of the 21st century, mainly in sustainability. This is the objective underpinning NEMESIS (NEw GEneration MEthods for Numerical SImulationS), an international researchproject involving Politecnico di Milano and Università di Milano-Bicocca, which today has been awarded one of the 37 Synergy Grants by the European Research Council (ERC). ERC Synergy Grants fund research on topics that are ambitious and complex ...
Analysis finds diversity on the smallest scales in sulfur-cycling salt marsh microbes
2023-10-26
WOODS HOLE, Mass.— At the surface, salt marshes and their windswept grasses can look deceptively simple. But those marshes are teeming with biodiversity, from the insects and migrating birds in the air all the way down to the microbes that live in the soil. Scientists from the Marine Biological Laboratory (MBL) have discovered that even among the sulfur-cycling microbes that are responsible for the “rotten egg gas” smell in salt marsh air, diversity extends all the way to genomes and even to individual nucleotides.
To ...
Stunting in infancy linked to differences in cognitive and brain function
2023-10-26
Children who are too short for their age can suffer reduced cognitive ability arising from differences in brain function as early as six months of age, according to new research from the University of East Anglia.
Researchers compared the ‘visual working memory’ – the memory capacity that holds visual cues for processing – in children who had stunted growth with those having typical growth.
Published today in the journal Nature Human Behaviour, the study found that the visual ...
New nanoparticles found to be effective for the treatment of rheumatoid arthritis
2023-10-26
A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science Center (IBS), in collaboration with researchers from Korea Institute of Science and Technology (KIST) and the Seoul National University, developed a new solution for the treatment of rheumatoid arthritis (RA).
RA is a chronic disease that, unfortunately, has no cure. The disease triggers a mix of troublesome symptoms like inflamed joints, harmful cytokines, and immune system imbalances, which work together to create a relentless cycle of worsening symptoms. While targeting ...
Admissions for bronchiolitis at children’s hospitals before and during the pandemic
2023-10-26
About The Study: The results of this study of 41 large U.S. children’s hospitals suggest that bronchiolitis hospitalizations decreased transiently and then increased markedly during the COVID-19 pandemic era. Patients admitted during the pandemic era were older and were more likely to be admitted to an intensive care unit. These findings suggest that bronchiolitis seasonality has not yet returned to pre-pandemic patterns, and hospitals should prepare for the possibility of atypical timing again in 2023.
Authors: Jonathan H. Pelletier, ...
Parent-perceived benefits and harms associated with internet use by adolescent offspring
2023-10-26
About The Study: This survey study of attitudes of 1,005 parents of children and adolescents ages 9 to 15 revealed both perceived benefits (e.g., family connectedness) and concerns (e.g., cyberbullying, addiction) of internet use. Twice as many parents reported specific concerns about internet addiction than substance addiction.
Authors: Michael Peter Milham, M.D., Ph.D., of the Child Mind Institute in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.39851
Editor’s ...
How adults understand what kids are saying
2023-10-26
CAMBRIDGE, MA -- When babies first begin to talk, their vocabulary is very limited. Often one of the first sounds they generate is “da,” which may refer to dad, a dog, a dot, or nothing at all.
How does an adult listener make sense of this limited verbal repertoire? A new study from MIT and Harvard University researchers has found that adults’ understanding of conversational context and knowledge of mispronunciations that children commonly make are critical to the ability to understand children’s early linguistic efforts.
Using ...
DNA Origami nanoturbine sets new horizon for nanomotors
2023-10-26
Nanoturbines: the heart of advancements
Flow-driven turbines lie at the heart of many revolutionary machines that have shaped our societies, from windmills to airplanes. Even life itself depends critically on turbines for fundamental processes, such as the FoF1-ATP synthase that produces fuels for biological cells and the bacterial flagella motor that propels bacteria. “Our nanoturbine has a 25-nanometer diameter rotor made from DNA material with blades configured in a right-handed or left-handed sense to control the direction of rotation. To operate, this structure is ...
NSF awards up to $21.4M for design of next-gen telescopes to capture earliest moments of universe
2023-10-26
The National Science Foundation has awarded $3.7 million to the University of Chicago for the first year of a grant that may provide up to $21.4 million for the final designs for a next-generation set of telescopes to map the light from the earliest moments of the universe—the Cosmic Microwave Background.
Led by the University of Chicago and Lawrence Berkeley National Laboratory, the collaboration seeks to build telescopes and infrastructure in both Antarctica and Chile to search for what are known as “primordial” gravitational waves—the vibrations from the Big Bang itself. It would also map the microwave light ...